Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer
about
Major clinical research advances in gynecologic cancer in 2015Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.Demethoxycurcumin inhibited human epithelia ovarian cancer cells' growth via up-regulating miR-551a.The Promise of Targeting Macrophages in Cancer Therapy.The Multifaceted Role of Perivascular Macrophages in Tumors.Modulation of long-term endothelial-barrier integrity is conditional to the cross-talk between Akt and Src signaling.Tumour-associated macrophages as treatment targets in oncology.Tumor-Associated Macrophages as Target for Antitumor Therapy.Immune Cell Population in Ovarian Tumor Microenvironment.Perivascular Macrophages Limit Permeability.Imaging of Tumor-Associated Macrophages in a Transgenic Mouse Model of Orthotopic Ovarian Cancer.The roles of CSFs on the functional polarization of tumor-associated macrophages.Therapy of primary and metastatic liver cancer by human iPS cell-derived myeloid cells producing interferon-β.Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance.CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis.Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancerRegulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
P2860
Q28077183-687382F5-CC57-41EA-B82C-7EB8B0E3A692Q33853991-0D5E3255-E09E-4C48-A961-46426C183575Q36983860-4EDAC0A8-78BC-4FCB-9B58-F809DE0D829FQ37079141-426C89C1-F05D-4298-8B1E-BA27B2D58562Q38710398-5533D4C9-3D6F-4CA3-9B5A-5A50674E1BFEQ38877313-6A186F9D-B09C-455C-B52A-1120DC11E935Q38895474-13BBD73B-3B57-4D73-8F07-47E8367BE44EQ39027593-F4CB7AE5-8B2C-43C4-A6AE-50B64CB01F01Q39100693-049A95D6-9783-4CB1-B68C-3804555983E4Q39403895-6F1A56EA-C8F5-472E-8FC3-AE938072D803Q41721704-5442D296-38E0-44B2-B62C-E7F3A194C957Q42679314-03D5F49D-3951-410E-AA5F-B183A72B81C5Q48199574-78C023D1-6C8D-4888-89B5-7EB5FAA413CEQ49684254-DBDA06C8-9A02-4109-A69F-C348243F97D5Q51240866-BD419288-0419-44AE-8510-4A713F6C7DDEQ55118405-5425BE65-5CD3-4494-9244-20EED84BBD94Q55381087-9DCE9179-E3F4-40E4-B6B7-6E5A1D356C0EQ58542923-7A113552-3D82-4799-91A7-DEB44D495132Q58773649-3C76E7D4-3B93-49B7-BD79-C9D2D364C28F
P2860
Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Macrophage Blockade Using CSF1 ...... tage Epithelial Ovarian Cancer
@ast
Macrophage Blockade Using CSF1 ...... tage Epithelial Ovarian Cancer
@en
type
label
Macrophage Blockade Using CSF1 ...... tage Epithelial Ovarian Cancer
@ast
Macrophage Blockade Using CSF1 ...... tage Epithelial Ovarian Cancer
@en
prefLabel
Macrophage Blockade Using CSF1 ...... tage Epithelial Ovarian Cancer
@ast
Macrophage Blockade Using CSF1 ...... tage Epithelial Ovarian Cancer
@en
P2093
P2860
P1433
P1476
Macrophage Blockade Using CSF1 ...... tage Epithelial Ovarian Cancer
@en
P2093
Crystal Lin
John David
M Luisa Iruela-Arispe
Madeeha Yaqoob
Oliver Dorigo
Shiruyeh Schokrpur
Ziyue Karen Jiang
P2860
P304
P356
10.1158/0008-5472.CAN-14-3373
P407
P577
2015-10-15T00:00:00Z